Susanna Naggie, MD
Duke University · Duke Clinical Research Institute · Duke University Medical Center CRS
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Susanna Naggie, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:26 UTC. Open this list on ClinicalTrials.gov
- Ph4NCT07560046 · Combating Related Epidemics in HCVDuke University · not yet recruiting · HIV - Human Immunodeficiency Virus, Hepatitis B Virus (HBV), HEPATITIS C (HCV) · principal investigator
- Ph3NCT06042855 · ACTIV-6: COVID-19 Study of Repurposed Medications - Arm G (Metformin)Susanna Naggie, MD · completed · Covid19 · principal investigator
- Ph3NCT05894564 · ACTIV-6: COVID-19 Study of Repurposed Medications - Arm E (Fluvoxamine 100)Susanna Naggie, MD · completed · Covid19 · principal investigator
- Ph3NCT05894577 · ACTIV-6: COVID-19 Study of Repurposed Medications - Arm F (Montelukast)Susanna Naggie, MD · completed · Covid19 · principal investigator
- Ph3NCT05894538 · ACTIV-6: COVID-19 Study of Repurposed Medications - Arm D (Ivermectin 600)Susanna Naggie, MD · completed · Covid19 · principal investigator
- Ph3NCT05890586 · ACTIV-6: COVID-19 Study of Repurposed Medications - Arm B (Fluvoxamine)Susanna Naggie, MD · completed · Covid19 · principal investigator
- Ph3NCT05736874 · ACTIV-6: COVID-19 Study of Repurposed Medications - Arm C (Fluticasone)Susanna Naggie, MD · completed · Covid19 · principal investigator
- Ph3NCT05736861 · ACTIV-6: COVID-19 Study of Repurposed Medications - Arm A (Ivermectin 400)Susanna Naggie, MD · completed · Covid19 · principal investigator
- Ph3NCT04885530 · ACTIV-6: COVID-19 Study of Repurposed MedicationsSusanna Naggie, MD · completed · Covid19 · principal investigator
- Ph2NCT04042740 · Glecaprevir/Pibrentasvir Fixed-dose Combination Treatment for Acute Hepatitis C Virus InfectionAdvancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections · completed · Hepatitis C Infection, HIV Infection · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 10:26 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Combating Related Epidemics in HCV through Simplified Testing and Treatment (CREST)U01AI195193 · NIAID · DUKE UNIVERSITY · PI Susanna Naggie · fiscal years 2025 to 2026Named on NCT07560046
- Center for Innovative TRIals in ChilDrEN and AdulTs (TRIDENT)U24TR001608 · NCATS · DUKE UNIVERSITY · PI DANIEL K. BENJAMIN, Gordon Raphael Bernard · fiscal years 2016 to 2022Named on NCT06042855, NCT05894564, NCT05894577, NCT05894538, NCT05890586, NCT05736874, NCT05736861, NCT04885530
- Leadership and Operations Center (LOC), AIDS Clinical Trials GroupUM1AI068636 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Joseph J Eron, RAJESH T GANDHI · fiscal years 2011 to 2026Named on NCT04042740
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.